Voltar
Revisão Produção Nacional Revisado por pares
BIBTEX RIS

Ticagrelor monotherapy after ≤ 1-month DAPT vs continued DAPT in patients with acute coronary syndrome treated with percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials

2024; Elsevier BV; Volume: 49; Issue: 12 Linguagem: Inglês

10.1016/j.cpcardiol.2024.102868

ISSN

1535-6280

Autores

Elizabet Taylor Pimenta Weba, Alexandros Páris de Mesquita Ipácio, David Abraham Batista da Hora, Christian Fukunaga, Maria Tereza Camarotti, Arthur Parke Costa Corvelo, André Luiz Carvalho Ferreira,

Tópico(s)

Coronary Interventions and Diagnostics

Resumo

Current guidelines recommend at least 12 months of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). However, DAPT prolonged use may increase the risk of bleeding complications. Therefore, we aimed to perform a meta-analysis to assess whether ticagrelor monotherapy after ≤1 month of DAPT improves clinical outcomes compared with continued DATP in acute coronary syndrome (ACS) patients post-PCI.

Referência(s)